We are live on ! Find out more
KOC

Koss-Olinger Consulting Portfolio holdings

AUM $1.19B
1-Year Est. Return 15.91%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+15.91%
3 Year Est. Return
+50.95%
5 Year Est. Return
+57.89%
10 Year Est. Return
AUM
$649M
AUM Growth
+$35M
Cap. Flow
+$5.38M
Cap. Flow %
0.83%
Top 10 Hldgs %
70.02%
Holding
266
New
37
Increased
83
Reduced
80
Closed
51

Sector Composition

Rank Sector Weight
1 Healthcare 2.71%
2 Technology 1.98%
3 Financials 1.45%
4 Consumer Staples 1.43%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
26
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$2.02M 0.31%
+40,760
New +$2.06M
XOM icon
27
ExxonMobil
XOM
$642B
$1.81M 0.28%
29,598
+1,569
+6% +$98.1K
VRTX icon
28
Vertex Pharmaceuticals
VRTX
$122B
$1.78M 0.27%
8,120
+4,355
+116% +$847K
MRK icon
29
Merck
MRK
$323B
$1.74M 0.27%
22,665
-4,126
-15% -$329K
CI icon
30
Cigna
CI
$77B
$1.7M 0.26%
7,411
+3,976
+116% +$845K
VOO icon
31
Vanguard S&P 500 ETF
VOO
$968B
$1.57M 0.24%
3,590
-3,070
-46% -$1.3M
SDY icon
32
State Street SPDR S&P Dividend ETF
SDY
$22B
$1.54M 0.24%
11,902
-50
-0.4% -$6.22K
WFC icon
33
Wells Fargo
WFC
$264B
$1.53M 0.24%
31,917
+2,272
+8% +$112K
CVS icon
34
CVS Health
CVS
$137B
$1.49M 0.23%
14,449
-4,334
-23% -$400K
KO icon
35
Coca-Cola
KO
$362B
$1.48M 0.23%
25,014
+1,409
+6% +$78.5K
MSFT icon
36
Microsoft
MSFT
$2.89T
$1.43M 0.22%
4,261
-1,041
-20% -$338K
NUBD icon
37
Nuveen ESG US Aggregate Bond ETF
NUBD
$465M
$1.29M 0.2%
50,301
+14,935
+42% +$385K
IWS icon
38
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$1.29M 0.2%
10,544
-19
-0.2% -$2.27K
INTC icon
39
Intel
INTC
$462B
$1.28M 0.2%
24,870
-18,693
-43% -$956K
TTWO icon
40
Take-Two Interactive
TTWO
$45.3B
$1.25M 0.19%
7,018
+1,838
+35% +$320K
EFAD icon
41
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$61.7M
$1.24M 0.19%
27,082
-1,965
-7% -$91.4K
EFG icon
42
iShares MSCI EAFE Growth ETF
EFG
$16.4B
$1.24M 0.19%
11,235
-40
-0.4% -$4.38K
SRVR icon
43
Pacer Data & Infrastructure Real Estate ETF
SRVR
$376M
$1.23M 0.19%
28,515
-8,101
-22% -$329K
EMDV icon
44
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.19M
$1.22M 0.19%
21,245
-946
-4% -$54.5K
CRM icon
45
Salesforce
CRM
$142B
$1.2M 0.19%
4,736
+284
+6% +$79.8K
JLL icon
46
Jones Lang LaSalle
JLL
$15.5B
$1.17M 0.18%
4,334
-74
-2% -$19.1K
BUD icon
47
AB InBev
BUD
$156B
$1.14M 0.18%
18,891
-829
-4% -$48.2K
PG icon
48
Procter & Gamble
PG
$346B
$1.1M 0.17%
6,729
-10
-0.1% -$1.49K
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$3.99T
$1.09M 0.17%
7,560
+3,040
+67% +$438K
RSPT icon
50
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.43B
$1.07M 0.16%
32,910
-12,490
-28% -$387K

Similar funds

Koss-Olinger Consulting's Q4 2021 Portfolio in Review

As of Q4 2021, Koss-Olinger Consulting held 266 positions worth $649M, up 5.7% from $614M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Koss-Olinger Consulting's Q4 2021 filing shows 37 new, 83 increased, 80 reduced and 51 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 40,760 shares worth $2.02M. The largest sale was VanEck Emerging Markets High Yield Bond ETF, an estimated $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 3.2% a quarter earlier, followed by Technology and Financials.

  • Koss-Olinger Consulting's largest Q4 2021 buy was Vanguard FTSE Emerging Markets ETF: 40,760 shares worth $2.02M.
  • Koss-Olinger Consulting added most to Vanguard Total Bond Market in Q4 2021, an estimated $36.2M increase.
  • Koss-Olinger Consulting's biggest Q4 2021 reduction was VanEck Emerging Markets High Yield Bond ETF, cutting an estimated $34.6M.
  • Koss-Olinger Consulting fully exited Arcturus Therapeutics in Q4 2021, selling an estimated $2.09M.
  • Koss-Olinger Consulting's ten largest holdings make up 70% of its $649M portfolio in Q4 2021.
  • Koss-Olinger Consulting opened 37 new positions and closed 51 in Q4 2021.
  • Koss-Olinger Consulting's portfolio value rose 5.7% quarter-over-quarter to $649M.

Based on Koss-Olinger Consulting's 13F filing for Q4 2021, filed 7 Feb 2022.